Filgotinib as Induction and Maintenance Therapy for Ulcerative Colitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Filgotinib as Induction and Maintenance Therapy for Ulcerative Colitis (SELECTION): A Phase 2b/3 Double-blind, Randomised, Placebo-Controlled Trial
Lancet 2021 Jun 03;[EPub Ahead of Print], BG Feagan, S Danese, EV Loftus, S Vermeire, S Schreiber, T Ritter, R Fogel, R Mehta, S Nijhawan, R Kempiński, R Filip, I Hospodarskyy, U Seidler, F Seibold, ILP Beales, HJ Kim, J McNally, C Yun, S Zhao, X Liu, CH Hsueh, C Tasset, R Besuyen, M Watanabe, WJ Sandborn, G Rogler, T Hibi, L Peyrin-BirouletFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.